Benzoic Acid

Benzoic Acid

SCHEMBL4998239

CC(=O)Nc1cc(Cl)c(O)cc1OC[C@@](C)(O)CNC1CCN(Cc2ccc(Cl)cc2)CC1.O=C(O)c1ccccc1

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D

The experimentally established mechanism targets of Benzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 2/20 0.72
CCR1 P32246 1/20 0.72
CCR5 P51681 5/20 0.41
SIGMAR1 Q99720 2/20 0.41
MAOB P27338 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
BACE1 P56817 1/20 0.40
MCHR1 Q99705 1/20 0.39
SLC6A12 P48065 1/20 0.39
CCR2 P41597 1/20 0.39
DRD4 P21917 1/20 0.38
LTA4H P09960 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1950538 0.94 CCR1 (0.80) ABCB11CCR1CCR5SIGMAR1MAOB
Sulfuric Acid SCHEMBL1952168 0.91 CCR1 (0.76) ABCB11CCR1CCR5SIGMAR1MEN1
Azd4818 SCHEMBL2061809 0.90 CCR1 (0.88) ABCB11CCR1CCR5SIGMAR1MAOB
SCHEMBL4998454 0.90 CCR1 (0.68) ABCB11CCR1CCR5SIGMAR1MAOB
SCHEMBL4668083 0.89 ABCB11 (0.73) ABCB11CCR1CCR5SIGMAR1MAOB
SCHEMBL4666529 0.89 ABCB11 (0.73) ABCB11CCR1CCR5SIGMAR1MAOB
SCHEMBL4666533 0.88 ABCB11 (0.61) ABCB11CCR1CCR5SIGMAR1MAOB
SCHEMBL3675985 0.86 CCR1 (0.68) ABCB11CCR1CCR5SIGMAR1MEN1
SCHEMBL3810728 0.84 ABCB11 (1.00) ABCB11CCR1CCR5SIGMAR1MEN1
SCHEMBL3807493 0.84 ABCB11 (1.00) ABCB11CCR1CCR5SIGMAR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194632-A1 Novel Piperidine Derivatives as Chemokine Receptor Modulators Useful for the Treatment of Respiratory Diseases ASTRAZENECA AB (SE) 2008-08-14 US claimed
US-20080194632-A1 Novel Piperidine Derivatives as Chemokine Receptor Modulators Useful for the Treatment of Respiratory Diseases ASTRAZENECA AB (SE) 2008-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194632-A1 Novel Piperidine Derivatives as Chemokine Receptor Modulators Useful for the Treatment of Respiratory Diseases ACKR3, CCR5, CCR2 ABCB11 760/4885CCR1 4/4885CCR5 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.